J.Henderson H.BioTech.F.A2/ LU1897414303 /
| NAV6/6/2023 | Chg.+0.1400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 20.8300USD | +0.68% | reinvestment | Equity Worldwide | Janus Henderson Inv. ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 16.00 | 5.22 | -0.35 | -3.20 | -4.78 | 5.21 | -2.20 | -2.06 | -4.69 | 7.33 | 11.32 | 4.71 | +34.70% |
| 2020 | -2.41 | -6.33 | -4.92 | 15.33 | 6.49 | 10.98 | 1.69 | 2.27 | 2.54 | 1.08 | 13.95 | 10.87 | +61.32% |
| 2021 | 1.29 | 1.03 | -4.47 | 1.83 | -3.70 | 2.96 | -4.64 | 9.20 | -2.18 | 0.79 | -8.49 | 2.25 | -5.17% |
| 2022 | -18.84 | -1.10 | 0.59 | -9.55 | -5.32 | 2.12 | 4.98 | 6.44 | 3.79 | 8.26 | 4.62 | 3.73 | -3.78% |
| 2023 | 2.07 | -3.15 | 1.93 | 4.49 | 4.04 | 3.68 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 20.01% | 19.70% | 23.80% | 25.07% | -% |
| Sharpe ratio | 1.57 | 1.77 | 2.47 | 0.49 | - |
| Best month | +4.49% | +4.49% | +8.26% | +13.95% | +16.00% |
| Worst month | -3.15% | -3.15% | -3.15% | -18.84% | -18.84% |
| Maximum loss | -8.27% | -8.27% | -9.58% | -46.36% | - |
| Outperformance | -2.63% | - | +16.67% | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| J.Henderson H.BioTech.F.IU2 | reinvestment | 21.1000 | +62.68% | +55.49% | |
| J.Henderson H.BioTech.F.A2 | reinvestment | 20.8300 | +61.98% | +54.64% | |
| J.Henderson H.BioTech.F.H2 | reinvestment | 20.9700 | +61.81% | +54.42% |
Performance
| YTD | +13.58% | ||
|---|---|---|---|
| 6 Months | +17.55% | ||
| 1 Year | +61.98% | ||
| 3 Years | +54.64% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +108.30% | ||
| Year | |||
| 2022 | -3.78% | ||
| 2021 | -5.17% | ||
| 2020 | +61.32% | ||
| 2019 | +34.70% | ||